Literature DB >> 20878207

Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis.

Phulwinder K Grover1, Jennifer E Hardingham, Adrian G Cummins.   

Abstract

Olfactomedin 4 (OLFM4), a member of the olfactomedin domain-containing proteins, is a glycoprotein with molecular weight of approximately 64 kDa. The protein is a "robust marker" of Lgr5+ stem cells and has been localised to mitochondria, nuclei and cell membranes. The bulk of OLFM4 exists in a polymeric form which is held together by disulfide bonds and carbohydrate interactions. Earlier studies revealed that the protein binds to lectins and cadherins, and facilitates cell-cell adhesion. Recent data demonstrated that the protein possesses several hallmarks of carcinogenesis. OLFM4 has also been purported to be an inducible resistance factor to apoptotic stimuli such as radiation and anticancer drugs. Here, we review its synonyms and classification, gene structure, protein structure, intracellular and tissue distribution, adhesive and antiapoptotic; mitotic; migratory and cell cycle regulatory characteristics. We also critically evaluate recent advances in understanding of the transcriptional regulation of OLFM4 and its upstream signalling pathways with special emphasis on carcinogenesis and outline future perspectives in the field.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878207     DOI: 10.1007/s10555-010-9262-z

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  25 in total

1.  Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock.

Authors:  Matthew N Alder; Amy M Opoka; Patrick Lahni; David A Hildeman; Hector R Wong
Journal:  Crit Care Med       Date:  2017-04       Impact factor: 7.598

2.  A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.

Authors:  Damien Besson; Aude-Hélène Pavageau; Isabelle Valo; Anthony Bourreau; Audrey Bélanger; Caroline Eymerit-Morin; Alice Moulière; Agnès Chassevent; Michelle Boisdron-Celle; Alain Morel; Jerôme Solassol; Mario Campone; Erick Gamelin; Benjamin Barré; Olivier Coqueret; Catherine Guette
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

3.  Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes.

Authors:  Key Sun Park; Kee Kwang Kim; Zheng-Hao Piao; Mi Kyung Kim; Hyun Jean Lee; Yong Chan Kim; Ki Sung Lee; Jeung-Hoon Lee; Kyoon Eon Kim
Journal:  Mol Cells       Date:  2012-11-15       Impact factor: 5.034

4.  Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.

Authors:  Bo Gun Jang; Byung Lan Lee; Woo Ho Kim
Journal:  Virchows Arch       Date:  2015-06-13       Impact factor: 4.064

Review 5.  Sepsis Biomarkers.

Authors:  Hector R Wong
Journal:  J Pediatr Intensive Care       Date:  2019-01-11

6.  The expression of REG 1A and REG 1B is increased during acute amebic colitis.

Authors:  Kristine M Peterson; Xiaoti Guo; Abdel G Elkahloun; Dinesh Mondal; Pradip K Bardhan; Akira Sugawara; Priya Duggal; Rashidul Haque; William A Petri
Journal:  Parasitol Int       Date:  2011-05-06       Impact factor: 2.230

7.  Juvenile OLFM4-null mice are protected from sepsis.

Authors:  Julie E Stark; Amy M Opoka; Jaya Mallela; Prasad Devarajan; Qing Ma; Nick C Levinsky; Keith F Stringer; Hector R Wong; Matthew N Alder
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

8.  Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor development.

Authors:  Antonina Giammanco; Valerie Blanc; Grace Montenegro; Coen Klos; Yan Xie; Susan Kennedy; Jianyang Luo; Sung-Hee Chang; Timothy Hla; Ilke Nalbantoglu; Sekhar Dharmarajan; Nicholas O Davidson
Journal:  Cancer Res       Date:  2014-08-01       Impact factor: 12.701

Review 9.  Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.

Authors:  Jennifer E Hardingham; Phulwinder Grover; Marnie Winter; Peter J Hewett; Timothy J Price; Benjamin Thierry
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

10.  Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer.

Authors:  Chaoqian Liu; Yan Guo; Weiwei Wu; Zhenzhen Zhang; Lu Xu; Kainan Wu; Wei Hu; Guoping Liu; Junyi Shi; Cheng Xu; Jianwei Bi; Yuan Sheng
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.